232 related articles for article (PubMed ID: 16778096)
1. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Mitsiades CS; Poulaki V; Fanourakis G; Sozopoulos E; McMillin D; Wen Z; Voutsinas G; Tseleni-Balafouta S; Mitsiades N
Clin Cancer Res; 2006 Jun; 12(12):3705-12. PubMed ID: 16778096
[TBL] [Abstract][Full Text] [Related]
2. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
3. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
[TBL] [Abstract][Full Text] [Related]
4. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
Moriyama H; Yonehara S
Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase/nuclear factor-kappa B signaling pathway is involved in the regulation of IGF-I on Fas-associated death domain-like interleukin-1-converting enzyme-inhibitory protein expression in cultured FRTL thyroid cells.
Ren M; Guan Q; Zhong X; Gong B; Sun Y; Xin W; Guo J; Wang H; Gao L; Zhao J
J Mol Endocrinol; 2007 Jun; 38(6):619-25. PubMed ID: 17556532
[TBL] [Abstract][Full Text] [Related]
6. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes.
Gilot D; Serandour AL; Ilyin GP; Lagadic-Gossmann D; Loyer P; Corlu A; Coutant A; Baffet G; Peter ME; Fardel O; Guguen-Guillouzo C
Carcinogenesis; 2005 Dec; 26(12):2086-94. PubMed ID: 16033771
[TBL] [Abstract][Full Text] [Related]
7. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
Mezzanzanica D; Balladore E; Turatti F; Luison E; Alberti P; Bagnoli M; Figini M; Mazzoni A; Raspagliesi F; Oggionni M; Pilotti S; Canevari S
Clin Cancer Res; 2004 Aug; 10(15):5202-14. PubMed ID: 15297424
[TBL] [Abstract][Full Text] [Related]
8. Regulation of caspase-6 and FLIP by the AMPK family member ARK5.
Suzuki A; Kusakai G; Kishimoto A; Shimojo Y; Miyamoto S; Ogura T; Ochiai A; Esumi H
Oncogene; 2004 Sep; 23(42):7067-75. PubMed ID: 15273717
[TBL] [Abstract][Full Text] [Related]
9. Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling.
Palao G; Santiago B; Galindo MA; Rullas JN; Alcamà J; Ramirez JC; Pablos JL
Arthritis Rheum; 2006 May; 54(5):1473-81. PubMed ID: 16646028
[TBL] [Abstract][Full Text] [Related]
10. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
[TBL] [Abstract][Full Text] [Related]
11. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
12. FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells.
Rippo MR; Moretti S; Vescovi S; Tomasetti M; Orecchia S; Amici G; Catalano A; Procopio A
Oncogene; 2004 Oct; 23(47):7753-60. PubMed ID: 15334061
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid regulates Fas-induced apoptosis in Jurkat T cells: reversal of mitogen-mediated repression of Fas DISC assembly.
Engedal N; Auberger P; Blomhoff HK
J Leukoc Biol; 2009 Mar; 85(3):469-80. PubMed ID: 19112091
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling.
Kamarajan P; Sun NK; Chao CC
Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332
[TBL] [Abstract][Full Text] [Related]
15. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.
Algeciras-Schimnich A; Griffith TS; Lynch DH; Paya CV
J Immunol; 1999 May; 162(9):5205-11. PubMed ID: 10227994
[TBL] [Abstract][Full Text] [Related]
17. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.
Gröbner S; Adkins I; Schulz S; Richter K; Borgmann S; Wesselborg S; Ruckdeschel K; Micheau O; Autenrieth IB
Apoptosis; 2007 Oct; 12(10):1813-25. PubMed ID: 17624595
[TBL] [Abstract][Full Text] [Related]
18. FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication.
Maedler K; Fontana A; Ris F; Sergeev P; Toso C; Oberholzer J; Lehmann R; Bachmann F; Tasinato A; Spinas GA; Halban PA; Donath MY
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8236-41. PubMed ID: 12060768
[TBL] [Abstract][Full Text] [Related]
19. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
Wieckowski E; Atarashi Y; Stanson J; Sato TA; Whiteside TL
J Cell Biochem; 2007 Jan; 100(1):16-28. PubMed ID: 16888780
[TBL] [Abstract][Full Text] [Related]
20. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
